iAnthus Capital Holdings (2IA) AI Stock Analysis

iAnthus Capital Holdings

(Frankfurt:2IA)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Licensed Cannabis PlatformThe company has historically operated across multiple licensed cannabis activities, providing vertical capabilities from cultivation through retail. This platform can support product control and market access if restructuring restores operational continuity.

Negative Factors

Severe Revenue ContractionA sharp and sustained top-line decline weakens operating leverage, reduces the company’s ability to absorb fixed costs, and can erode market presence. Recovery would require renewed demand, stable operations, and successful execution across its regulated markets.

iAnthus Capital Holdings (2IA) vs. iShares MSCI Germany ETF (EWG)

Not enough price history over this period.

Market Cap: EUR 27.90M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -0.5
Beta (1Y): -2.20
Revenue Growth: -16.90%
EPS Growth: -1480.00%
Country: Germany
Employees: 741
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - Specialty & Generic

iAnthus Capital Holdings Business Overview & Revenue Model

Company Description

iAnthus Capital Holdings, Inc. is a U.S.-based cannabis enterprise that holds licenses for and actively manages cannabis cultivation, processing, and retail dispensary operations. Its diverse product portfolio encompasses both cannabis and cannabidio...

iAnthus Capital Holdings Risk Analysis

iAnthus Capital Holdings disclosed 67 risk factors in its most recent earnings report. iAnthus Capital Holdings reported the most risks in the "Legal & Regulatory" category.

Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

0 New Risks

iAnthus Capital Holdings Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:2IA against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TSE:GTII	72Outperform	CAD 1.90B	11.44	6.82%	―	3.81%	344.13%
TSE:CURA	56Neutral	CAD 3.12B	-60.28	-4.47%	―	1.50%	81.84%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:VRNO	51Neutral	CAD 2.17B	-1.66	-28.93%	―	0.61%	37.92%
TSE:CL	40Underperform	CAD 365.32M	-1.89	-28.27%	―	-5.83%	-115.39%

* Healthcare Sector Average

Performance Comparison

DE:2IA and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:2IA	Ianthus Capital Holdings (OTC)	―	―	―
TSE:CURA	Curaleaf Holdings (Otc)	11.77	0.04	0.34%
TSE:GTII	Green Thumb Industries (OTC)	8.70	-0.95	-9.84%
TSE:CL	Cresco Labs OTC	0.80	-0.83	-50.92%
TSE:VRNO	Verano Holdings Corp.	6.32	0.00	0.00%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

iAnthus Capital Holdings AI Stock Analysis